BombardieriE., CrippaF., MaffioliL., ChitiA., CastellaniM.R., GrecoM., AgrestiR., BogniA., ChiesaC., De SanctisV., MassaronS., PascaliC.: Axillary lymph node metastases detection with nuclear medicine approaches in patients with newly diagnosed breast cancer: can positron emission tomography (PET) with 18F-FDG be considered as the best method? Int. J. Oncol., 8: 693–699, 1996.
2.
ChitiA., MaffioliL.S., InfanteM., GrasselliG., IncarboneM., GaspariniM.D., SavelliG., BombardieriE.: Assessment of mediastinal involvement in lung cancer with 99mTc-sestaMIBI SPET. J. Nucl. Med., 37: 938–942, 1996.
3.
ChiuM.L., KronaugeJ. F., Piwnica-WormsD.: Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile)-technetium (I) in cultured mouse fibroblasts. J. Nucl. Med., 31: 1646–1653, 1990.
4.
EllP.J.: Keeping abreast of time. Eur. J. Nucl. Med., 22: 967–969, 1995.
5.
KhalkhaliI., MenaI., JouanneE.: Prone scintimammography in patients with suspicion of carcinoma of the breast. J. Am. Coll. Surg., 178: 491–497, 1994.
6.
KolscielnyS., MgLe, TubianaM.: The natural history of human breast cancer. The relationship between involvement of axillary lymph nodes and the initiation of distant metastases. Br. J. Cancer, 59: 775–782, 1989.
7.
KrenningE.P., KwekkeboomD.J., BakkerW.H.:Somatostatin receptor scintigraphy with [111In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur. J. Nucl. Med., 20: 716–731; 1993.
8.
MaffioliL., AgrestiR., ChitiA., CrippaF., GaspariniM., GrecoM., BombardieriE.:Prone scintimammography in patients with non-palpable breast lesions. Anticancer Research, 16: 1296–1274; 1996.
9.
MaffioliL., SteensJ., PauwelsE.J., BombardieriE.: Applications of Tc-99m-sestamibi in oncology. Tumori, 82: 12–21, 1996.
10.
MaffioliL.S., GaspariniM., ChitiA., GramagliaA., MongiojV., PozziA., BombardieriE.: Clinical role of Tc99m-SestaMIBI SPET in evaluating pretreated patients with brain tumors. Eur. J. Nucl. Med., 23: 308–311, 1996.
11.
Van EijckC.H.J., KrenningE.P., BootsmaA., OeiH.Y., Van PelR., LindemansJ., JeekelJ., ReubiJ.C., LambertsS.W.K.: Somato-statin-receptor scintigraphy in primary breast cancer. Lancet, 343: 640–643, 1994.
